Cargando…
Sugammadex as a reversal agent for neuromuscular block: an evidence-based review
Sugammadex is the first clinical representative of a new class of drugs called selective relaxant binding agents. It has revolutionized the way anesthesiologists think about drug reversal. Sugammadex selectively binds rocuronium or vecuronium, thereby reversing their neuromuscular blocking action. D...
Autores principales: | Schaller, Stefan Josef, Fink, Heidrun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789633/ https://www.ncbi.nlm.nih.gov/pubmed/24098155 http://dx.doi.org/10.2147/CE.S35675 |
Ejemplares similares
-
Sugammadex and Reversal of Neuromuscular Block in Adult Patient with Duchenne Muscular Dystrophy
por: Wefki Abdelgawwad Shousha, Ahmed Abdelgawwad, et al.
Publicado: (2014) -
Reversal of neuromuscular block with sugammadex in five heart transplant pediatric recipients
por: Carlos, Ricardo Vieira, et al.
Publicado: (2017) -
The influence of mild hypothermia on reversal of rocuronium-induced deep neuromuscular block with sugammadex
por: Lee, Hee Jong, et al.
Publicado: (2015) -
Update on the management of neuromuscular block: focus on sugammadex
por: de Boer, Hans D, et al.
Publicado: (2007) -
Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction
por: de Boer, Hans D, et al.
Publicado: (2018)